GENOMENON is one of those startups that local leaders get all warm and fuzzy about. The Ann Arbor-based company is a cross between life sciences and tech, and has a very promising future.
And then there are the startup resources that have been invested in its success. GENOMENON has leveraged just about every new economy startup program in southeast Michigan. It spun out of the University of Michigan, taking advantage of U-M's Office of Technology Transfer along the way. It has worked with Ann Arbor SPARK, the local small business development center, and the Great Lakes Entrepreneurs Quest initiative, among others.
"We have really maximized the resources in the Michigan startup community," says Dr. Mark Kiel, co-founder & CEO of GENOMENON
GENOMENON is the product of three U-M pathologists, including Dr. Kiel. They are developing software focused on interpreting the mountains of data that come from genome sequencing. The end result could lead to things like improving cancer diagnosis and treatment. Think of it as data analytics for genome sequencing.
"We can produce the data really efficiently," Dr. Kiel says. "It's interpreting the data that is the problem."
GENOMENON is currently made up of seven people after launching last May. It is currently looking to hire a handful of software developers.
"We need boots on the ground, people who can code," Dr. Kiel says.
Source: Dr. Mark Kiel, co-founder & CEO of GENOMENON
Writer: Jon Zemke
Read more about Metro Detroit's growing entrepreneurial ecosystem at SEMichiganStartup.com.